Product Information

DOFETILIDE 250 MCG CAPSULE is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.1925 per EA under NDC 76282075660. Its NADAC has been published 72 times since Apr 9, 2025.

FDA first approved this application on Oct 14, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DOFETILIDE 250 MCG CAPSULE

Dofetilide
$0.1925per EA

Strength

.25 mg/1

NDC

76282075660

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DOFETILIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA212750

FDA Approved

10/14/2021

TE Code

AB

On Market Since

11/1/2024

Pharmacological Classes

Price Statistics

The NADAC for DOFETILIDE 250 MCG CAPSULE has been published 72 times since Apr 9, 2025, and over the history we have for it it has declined 21.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1925 per EA
All-time high$0.2437 (Apr 16, 2025)
All-time low$0.1886 (Feb 18, 2026)
52-week high$0.2178
52-week low$0.1886
Median price$0.2067
Average price$0.2084
Largest weekly change-5.3% (Jun 18, 2025)
Weeks tracked72
Tracking sinceApr 9, 2025

Price History

1W

+1.0%

1M

+1.0%

3M

-0.6%

6M

+2.1%

1Y

-11.6%

3Y

N/A

5Y

N/A

All

-21.0%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DOFETILIDE 250 MCG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for DOFETILIDE 250 MCG CAPSULE, manufactured by Exelan Pharmaceuticals Inc., is $0.1925 per EA (NDC 76282075660), effective Aug 19, 2026.

How has the price of DOFETILIDE 250 MCG CAPSULE changed over time?

Over the history we have for it, the NADAC for DOFETILIDE 250 MCG CAPSULE has declined 21.0%. It has been tracked across 72 weekly CMS publications since Apr 9, 2025.

What are the highest and lowest recorded NADAC prices for DOFETILIDE 250 MCG CAPSULE?

Since Apr 9, 2025, the NADAC for DOFETILIDE 250 MCG CAPSULE has ranged from a low of $0.1886 (Feb 18, 2026) to a high of $0.2437 (Apr 16, 2025), with a median of $0.2067 per EA.

Are there cheaper alternatives to DOFETILIDE 250 MCG CAPSULE?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DOFETILIDE 250 MCG CAPSULE, is $0.1886 per EA — about 2% below DOFETILIDE 250 MCG CAPSULE.

Who manufactures DOFETILIDE 250 MCG CAPSULE?

DOFETILIDE 250 MCG CAPSULE (NDC 76282075660) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.